The restoration of CDK2 expression in NPCs after MTR4 knockdown (KD) partially rescues the proliferation of NPCs in vitro and tumorigenesis in vivo, indicating that MTR4 drives NPC tumorigenesis by maintaining the expression levels of key target cell cycle genes. Here, CDK2 is linked to nasopharyngeal carcinoma.